191 related articles for article (PubMed ID: 21128078)
1. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.
Biondi-Zoccai G; Sheiban I; Moretti C; Palmerini T; Marzocchi A; Capodanno D; Tamburino C; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; Pede Fd; Ramondo A; Medda M; de Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; Barlocco F; de Servi S
Clin Res Cardiol; 2011 May; 100(5):403-11. PubMed ID: 21128078
[TBL] [Abstract][Full Text] [Related]
2. Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function.
Bollati M; Gerasimou A; Sillano D; Biondi-Zoccai G; Garrone P; Moretti C; Sciuto F; Omedé P; Trevi GP; Sheiban I
Catheter Cardiovasc Interv; 2010 Mar; 75(4):586-93. PubMed ID: 20088012
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in patients undergoing percutaneous unprotected left main stenting.
Sheiban I; La Spina C; Cavallero E; Biondi-Zoccai G; Colombo F; Palmerini T; Marzocchi A; Tamburino C; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; di Pede F; Ramondo A; Fantoni C; de Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; de Servi S
EuroIntervention; 2010 Feb; 5(7):795-800. PubMed ID: 20142193
[TBL] [Abstract][Full Text] [Related]
5. Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry.
Sheiban I; Sillano D; Biondi-Zoccai G; Moretti C; Garrone P; Lombardi P; Sciuto F; Omedè P; Iacovino C; Spina CL; Trevi GP
J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):461-8. PubMed ID: 19395977
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
7. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
[TBL] [Abstract][Full Text] [Related]
8. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
[TBL] [Abstract][Full Text] [Related]
9. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
[TBL] [Abstract][Full Text] [Related]
10. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
11. [Long-term outcomes of implanting drug-eluting stents for unprotected left main coronary artery disease patients with left ventricular systolic dysfunction].
Pan Y; Qiu Q; Ren WH; Yu XP; Li Q; Ren XJ
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(46):3612-3616. PubMed ID: 29275602
[No Abstract] [Full Text] [Related]
12. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
13. High-risk diabetic patients with unprotected left main coronary artery disease: characteristics and medium-term outcomes of percutaneous revascularization with drug-eluting stents.
Fernández JF; González CS; Navarro MJ; Fernández Guerrero JC; Menchero AG; Briales JH; Piris RM; Herrador J; Herrera MG; García JM
Tex Heart Inst J; 2011; 38(4):386-91. PubMed ID: 21841866
[TBL] [Abstract][Full Text] [Related]
14. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
[TBL] [Abstract][Full Text] [Related]
15. Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry.
Biondi-Zoccai G; Sheiban I; Romagnoli E; De Servi S; Tamburino C; Colombo A; Burzotta F; Presbitero P; Bolognese L; Paloscia L; Rubino P; Sardella G; Briguori C; Niccoli L; Franco G; Di Girolamo D; Piatti L; Greco C; Capodanno D; Sangiorgi G
Clin Res Cardiol; 2011 Nov; 100(11):1021-8. PubMed ID: 21701872
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.
Brodie BR; Stuckey T; Downey W; Humphrey A; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Smith H; Edmunds J; Varanasi J; Simonton CA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):405-14. PubMed ID: 19463338
[TBL] [Abstract][Full Text] [Related]
19. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry).
Godino C; Parodi G; Furuichi S; Latib A; Barbagallo R; Goktekin O; Cera M; Mueller R; Tamburino C; Grube E; Di Mario C; Reimers B; Chieffo A; Antoniucci D; Colombo A; Sangiorgi GM
EuroIntervention; 2010 Apr; 5(8):906-16. PubMed ID: 20542775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
